Literature DB >> 1316868

Nonrandom orientation of transposon Tn5supF insertions in phage lambda.

D Kersulyte1, B R Krishnan, D E Berg.   

Abstract

Transposition of mini-transposon Tn5supF to phage lambda can be selected in two ways: (i) by plaque formation on a dnaB amber strain of Escherichia coli, which requires expression of the transposon-borne suppressor tRNA gene (supF) during lytic phage growth, or (ii) by lysogenization of a strain with amber mutations in tet and amp resistance genes, and selection of TcR ApR (Sup+) transductant colonies. Tn5supF insertions in several lambda clones were isolated and mapped using a polymerase chain reaction (PCR) amplification method. Among insertions selected during lytic growth, more than 90% were oriented such that supF could be transcribed from an upstream lambda promoter. In contrast, half of those selected by transduction were in each orientation. These results indicate that Tn5supF insertion occurs with equal frequency in each orientation. However, Tn5supF insertion phages in which transcription from the lambda and supF promoters would collide tend to be lost when supF is selected during lytic growth. The tendency to recover Tn5supF insertions in only one orientation is useful in a transposon- and crossover-PCR-based method for preparing templates for DNA sequencing.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316868     DOI: 10.1016/0378-1119(92)90712-x

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  2 in total

1.  Efficient large-scale sequencing of the Escherichia coli genome: implementation of a transposon- and PCR-based strategy for the analysis of ordered lambda phage clones.

Authors:  H Kasai; S Isono; M Kitakawa; J Mineno; H Akiyama; D M Kurnit; D E Berg; K Isono
Journal:  Nucleic Acids Res       Date:  1992-12-25       Impact factor: 16.971

2.  Viability of folA-null derivatives of wild-type (thyA+) Escherichia coli K-12.

Authors:  B R Krishnan; D E Berg
Journal:  J Bacteriol       Date:  1993-02       Impact factor: 3.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.